Creatine isn’t just for athletes. Here’s who should be taking it (hint: probably you) - Los Angeles Times
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
My boyfriend turned 50 this year. He didn’t buy an expensive sports car. Or quit his job and form a garage band. He started taking … creatine. “What is that, exactly?” I asked. “Oh, one of those things everyone takes after 50,” he said. Or 30. Or 80, as it turns out. My 84-year-old mom called just the other day: “What’s, um, cree-ah-teen?” She asked. “Oh, and what’s some new popular music I should be listening to?” (Mom stays on top of the trends.)Creatine seems to be everywhere lately, the “it” supplement. It crowds grocery store shelves and regularly pops up on social media. “Should you be having creatine?” one fitness influencer, @tashmaraiss, urged on TikTok (from, where else, the front seat of her car). “Only if you want to be absolutely jacked, smart and recovering [from workouts] faster.” Was that true? I set out to find out. So what’s the deal with this supplement? What it is: Creatine is a natural compound that helps power our muscles.
This article is an excerpt. To read the full content, visit the original source. Los Angeles Times
Related articles
People Are Dying of Heart Attacks at Nanaimo’s Outdated Hospital - The Tyee
Informations complètes et à jour, compilées par Google Actualités à partir de sources d'actualité du monde entier
Flagellin Antibody Predicts Future Crohn’s Disease - DocWireNews
AbstractBackground & AimsElevated antimicrobial antibodies have been reported up to 6 years before diagnosis of Crohn’s disease (CD), but the specific antibody response is unclear. Here, we characterized the antimicrobial antibody responses before CD diagnosis in healthy first-degree relatives (FDRs) of patients with CD. MethodsThe CCC-GEM (Crohn’s and Colitis Canada – Genetic, Environmental, Microbial) Project nested case-control cohort consisted of FDRs who later developed CD (n = 77), matched 1:4 by age, sex, follow-up duration, and geographical location with healthy FDRs (n = 304). Sera at enrollment were probed for antimicrobial reactivity using a microbiota antigen microarray and a flagellin peptide cytometric bead array. Conditional logistic regression was used to assess association with CD onset, and partial Spearman was used to correlate serologic responses with lactulose-to-mannitol ratio (LMR), C-reactive protein (CRP), and fecal calprotectin (FCP). False discovery rate was controlled using the Benjamini-Hochberg method (q < 0.05).
A rapid clinical care program increased cancer care access for vulnerable patients - Medical Xpress
The rapid-access cancer care program Same Day/Next Day (SDND) served a higher proportion of patients with high socioeconomic risk for poor outcomes than the traditional health care path, and more socially vulnerable patients initiated therapy, according to results presented at the 19th AACR Conference on The Science of Cancer Health Disparities, held Oct. 18–21 in Atlanta. "Delay in care is one of the largest negative predictors of cancer outcomes," said Joseph P. Flemming, D. O., from Jefferson Abington Hospital, who presented the study. "The SDND program rapidly connects patients with expert guidance to support them in navigating the beginning of their cancer journey. "
0 comments
No comments yet. Be the first to share your thoughts!